Literature DB >> 8035525

Complementation analysis of pseudorabies virus gE and gI mutants in retinal ganglion cell neurotropism.

L W Enquist1, J Dubin, M E Whealy, J P Card.   

Abstract

Pseudorabies virus glycoproteins gE and gI are required to infect some, but not all, regions of the rodent central nervous system after peripheral injection. After infection of the retina, pseudorabies virus mutants lacking either gE or gI can subsequently infect neural centers involved in the control of circadian function but cannot infect visual circuits mediating visual perception or the reflex movement of the eyes. In this study, we used genetic complementation to test the hypothesis that gE and gI are required for entry into the specific retinal ganglion cells that project to visual centers. These data strongly suggest that gE and gI must function after the viruses enter primary neurons in the retina.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035525      PMCID: PMC236473     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Role of a structural glycoprotein of pseudorabies in virus virulence.

Authors:  T C Mettenleiter; L Zsak; A S Kaplan; T Ben-Porat; B Lomniczi
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Role of pseudorabies virus glycoprotein gI in virus release from infected cells.

Authors:  T C Mettenleiter; C Schreurs; F Zuckermann; T Ben-Porat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

3.  Tensor tympani reflex pathways studied with retrograde horseradish peroxidase and transneuronal viral tracing techniques.

Authors:  E M Rouiller; M Capt; M Dolivo; F De Ribaupierre
Journal:  Neurosci Lett       Date:  1986-12-23       Impact factor: 3.046

4.  Neuronal and transneuronal tracing in the trigeminal system of the rat using the herpes virus suis.

Authors:  X Martin; M Dolivo
Journal:  Brain Res       Date:  1983-08-29       Impact factor: 3.252

5.  Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin.

Authors:  D C Johnson; V Feenstra
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

6.  Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines.

Authors:  W Quint; A Gielkens; J Van Oirschot; A Berns; H T Cuypers
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

7.  Presence of markers for virulence in the unique short region or repeat region or both of pseudorabies hybrid viruses.

Authors:  A Berns; A van den Ouweland; W Quint; J van Oirschot; A Gielkens
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Pseudorabies virus avirulent strains fail to express a major glycoprotein.

Authors:  T C Mettenleiter; N Lukàcs; H J Rziha
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Innervation of the heart and its central medullary origin defined by viral tracing.

Authors:  A Standish; L W Enquist; J S Schwaber
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

10.  Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.

Authors:  D C Johnson; M C Frame; M W Ligas; A M Cross; N D Stow
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  31 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.

Authors:  C E Saldanha; J Lubinski; C Martin; T Nagashunmugam; L Wang; H van Der Keyl; R Tal-Singer; H M Friedman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Intravitreal injection of the attenuated pseudorabies virus PRV Bartha results in infection of the hamster suprachiasmatic nucleus only by retrograde transsynaptic transport via autonomic circuits.

Authors:  Gary E Pickard; Cynthia A Smeraski; Christine C Tomlinson; Bruce W Banfield; Jessica Kaufman; Christine L Wilcox; Lynn W Enquist; Patricia J Sollars
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  Glycoproteins gM and gN of pseudorabies virus are dispensable for viral penetration and propagation in the nervous systems of adult mice.

Authors:  M J Masse; A Jöns; J M Dijkstra; T C Mettenleiter; A Flamand
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  The gE and gI homologs from two alphaherpesviruses have conserved and divergent neuroinvasive properties.

Authors:  A C Knapp; P J Husak; L W Enquist
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Structure-function analysis of the gE-gI complex of feline herpesvirus: mapping of gI domains required for gE-gI interaction, intracellular transport, and cell-to-cell spread.

Authors:  J D Mijnes; B C Lutters; A C Vlot; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Authors:  Alexander M Rowe; Hongming Yun; Benjamin R Treat; Paul R Kinchington; Robert L Hendricks
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

8.  The absence of glycoprotein gL, but not gC or gK, severely impairs pseudorabies virus neuroinvasiveness.

Authors:  A Flamand; T Bennardo; N Babic; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI.

Authors:  W Mulder; J Pol; T Kimman; G Kok; J Priem; B Peeters
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  A herpesvirus encoded deubiquitinase is a novel neuroinvasive determinant.

Authors:  Joy I Lee; Patricia J Sollars; Scott B Baver; Gary E Pickard; Mindy Leelawong; Gregory A Smith
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.